GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asia Green Biotechnology Corp (XCNQ:ASIA) » Definitions » EV-to-EBITDA

Asia Green Biotechnology (XCNQ:ASIA) EV-to-EBITDA : -7.39 (As of May. 17, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Asia Green Biotechnology EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Asia Green Biotechnology's enterprise value is C$0.79 Mil. Asia Green Biotechnology's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was C$-0.11 Mil. Therefore, Asia Green Biotechnology's EV-to-EBITDA for today is -7.39.

The historical rank and industry rank for Asia Green Biotechnology's EV-to-EBITDA or its related term are showing as below:

XCNQ:ASIA' s EV-to-EBITDA Range Over the Past 10 Years
Min: -15.21   Med: 0   Max: 0
Current: -7.39

XCNQ:ASIA's EV-to-EBITDA is not ranked
in the Drug Manufacturers industry.
Industry Median: 14.88 vs XCNQ:ASIA: -7.39

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-17), Asia Green Biotechnology's stock price is C$0.015. Asia Green Biotechnology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was C$-0.004. Therefore, Asia Green Biotechnology's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Asia Green Biotechnology EV-to-EBITDA Historical Data

The historical data trend for Asia Green Biotechnology's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asia Green Biotechnology EV-to-EBITDA Chart

Asia Green Biotechnology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
- -1.09 -5.54 -2.93 -4.23

Asia Green Biotechnology Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.14 -4.23 -6.66 -7.65 -5.71

Competitive Comparison of Asia Green Biotechnology's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Asia Green Biotechnology's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asia Green Biotechnology's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Asia Green Biotechnology's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Asia Green Biotechnology's EV-to-EBITDA falls into.



Asia Green Biotechnology EV-to-EBITDA Calculation

Asia Green Biotechnology's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.791/-0.107
=-7.39

Asia Green Biotechnology's current Enterprise Value is C$0.79 Mil.
Asia Green Biotechnology's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asia Green Biotechnology  (XCNQ:ASIA) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Asia Green Biotechnology's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.015/-0.004
=At Loss

Asia Green Biotechnology's share price for today is C$0.015.
Asia Green Biotechnology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.004.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Asia Green Biotechnology EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Asia Green Biotechnology's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Asia Green Biotechnology (XCNQ:ASIA) Business Description

Traded in Other Exchanges
N/A
Address
707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
Asia Green Biotechnology Corp is an early stage international agri-technology company focused on the development, evaluation, testing, application and, ultimately, supply to the market of proprietary organic hybridization technology and certain products derived from that technology. The core approach of the business is centred on the planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities. The company is developing varieties of hemp with superior growth and production characteristics in the various environments found in the licensed territories.

Asia Green Biotechnology (XCNQ:ASIA) Headlines

No Headlines